BIM
FLGT icon

Bogle Investment Management’s Fulgent Genetics FLGT Stock Holding History

Bogle Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,274
Closed -$411K – 189
2020
Q3 		$411K Sell
10,274
-1,230
-11% -$38.5K 0.12% 172
2020
Q2 		$184K Buy
+11,504
New +$176K 0.03% 294
2020
Q1 		– Sell
-14,906
Closed -$192K – 303
2019
Q4 		$192K Buy
+14,906
New +$177K 0.02% 245

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Bogle Investment Management's FLGT Position: Q4 2020 in Review

Bogle Investment Management sold out of Fulgent Genetics (FLGT) in Q4 2020, closing a stake of 10,274 shares — an estimated $411K sold.

Bogle Investment Management first reported a position in FLGT in Q4 2019 and held it in 3 quarters. The position peaked at $411K in Q3 2020. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2020.

  • Bogle Investment Management reported no remaining Fulgent Genetics position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 10,274 Fulgent Genetics shares in Q4 2020, an estimated $411K.
  • Bogle Investment Management first reported a position in Fulgent Genetics in Q4 2019 and held it in 3 quarters.
  • Bogle Investment Management's Fulgent Genetics position peaked at $411K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.